Though e-cigarettes have generally been viewed as “less risky” than conventional cigarettes, new research published in the American Journal of Preventive Medicine suggests the alternative can double the risk of developing myocardial infarction (MI).
Mothers who breastfed at least one child showed a 23 percent reduced risk of stroke compared to those who never breastfed, according to an observational study published Aug. 22 in the Journal of the American Heart Association.
The Avert system successfully reduced contrast media volume but failed to trim the risk of acute kidney injury (AKI) following coronary angiography, according to a trial published in JACC: Cardiovascular Interventions.
A new study published in the American Journal of Cardiology suggests women aged 45 and older who experienced traumatic life events could have a 37 percent increased chance of atrial fibrillation (AFib).
A handheld cardiac rhythm recorder that links to a smartphone application detected atrial fibrillation (AFib) with 96.6 percent sensitivity and 94.1 percent specificity compared to physician-interpreted electrocardiograms (ECGs), according to a single-center study published in HeartRhythm.
Weight gain after quitting smoking is associated with an increased short-term risk of type 2 diabetes (T2D), according to new research published in the New England Journal of Medicine.
Two researchers with Johns Hopkins University in Baltimore believe community-based organizations (CBOs) must become involved to adequately address food insecurity among high-risk Medicaid patients.
The same investigators who ignited debate among interventional cardiologists with the ORBITA trial in November 2017 have now published a small study highlighting the ability of percutaneous coronary intervention (PCI) to immediately reduce ischemia and boost patients’ exercise capacity.
More than 100,000 individuals across the nation learned about hands-only CPR through training kiosks since the American Heart Association (AHA), along with Anthem Foundation, launched its program in 2016.
The publicly available prices of 30 frequently prescribed cardiovascular drugs don’t necessarily correlate to clinical value, according to a new study. Some drugs were both cheaper and more effective than alternatives, while others were more expensive and associated with poorer outcomes.
